Trial Profile
A Retrospective, Multicenter, Cohort Study Assessing the Efficacy of Ustekinumab for Maintaining Clinical, Endoscopic, and Radiographic Response in Patients with Moderate-to-Severe Crohn's Disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Apr 2018
Price :
$35
*
At a glance
- Drugs Ustekinumab (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- 02 Apr 2018 New trial record